BNPMDA: Bipartite Network Projection for MiRNA–Disease Association prediction

Motivation A large number of resources have been devoted to exploring the associations between microRNAs (miRNAs) and diseases in the recent years. However, the experimental methods are expensive and time-consuming. Therefore, the computational methods to predict potential miRNA-disease associations have been paid increasing attention. Results In this paper, we proposed a novel computational model of Bipartite Network Projection for MiRNA-Disease Association prediction (BNPMDA) based on the known miRNA-disease associations, integrated miRNA similarity and integrated disease similarity. We firstly described the preference degree of a miRNA for its related disease and the preference degree of a disease for its related miRNA with the bias ratings. We constructed bias ratings for miRNAs and diseases by using agglomerative hierarchical clustering according to the three types of networks. Then, we implemented the bipartite network recommendation algorithm to predict the potential miRNA-disease associations by assigning transfer weights to resource allocation links between miRNAs and diseases based on the bias ratings. BNPMDA had been shown to improve the prediction accuracy in comparison with previous models according to the area under the receiver operating characteristics (ROC) curve (AUC) results of three typical cross validations. As a result, the AUCs of Global LOOCV, Local LOOCV and 5-fold cross validation obtained by implementing BNPMDA were 0.9028, 0.8380 and 0.8980 ± 0.0013, respectively. We further implemented two types of case studies on several important human complex diseases to confirm the effectiveness of BNPMDA. In conclusion, BNPMDA could effectively predict the potential miRNA-disease associations at a high accuracy level. Availability and implementation BNPMDA is available via http://www.escience.cn/system/file?fileId=99559. Supplementary information Supplementary data are available at Bioinformatics online.

[1]  Bernhard Puppe,et al.  MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. , 2011, Blood.

[2]  Qionghai Dai,et al.  WBSMDA: Within and Between Score for MiRNA-Disease Association prediction , 2016, Scientific Reports.

[3]  Qionghai Dai,et al.  RBMMMDA: predicting multiple types of disease-microRNA associations , 2015, Scientific Reports.

[4]  M. von Brandenstein,et al.  MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples. , 2012, The American journal of pathology.

[5]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.

[6]  A. Pasquinelli,et al.  A sense-able microRNA , 2016, Genes & development.

[7]  Ujjwal Maulik,et al.  Development of the human cancer microRNA network , 2010 .

[8]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[9]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[10]  Fang Zhou,et al.  Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. , 2008, Cancer research.

[11]  Yi-Cheng Zhang,et al.  Bipartite network projection and personal recommendation. , 2007, Physical review. E, Statistical, nonlinear, and soft matter physics.

[12]  Frank J. Slack,et al.  The Role of MicroRNAs in Cancer , 2006, The Yale journal of biology and medicine.

[13]  Xi Chen,et al.  Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls. , 2012, Carcinogenesis.

[14]  Yi Wang,et al.  Circulating miR-155 Expression in Plasma: A Potential Biomarker for Early Diagnosis of Esophageal Cancer in Humans , 2012, Journal of toxicology and environmental health. Part A.

[15]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[16]  Xing Chen,et al.  Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.

[17]  P. Leedman,et al.  Regulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7 , 2012, PloS one.

[18]  Yadong Wang,et al.  Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.

[19]  Xia Li,et al.  Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes , 2013, BMC Systems Biology.

[20]  J. H. Ward Hierarchical Grouping to Optimize an Objective Function , 1963 .

[21]  Xing Chen,et al.  HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction , 2016, Oncotarget.

[22]  Shangwei Ning,et al.  Prioritizing human cancer microRNAs based on genes’ functional consistency between microRNA and cancer , 2011, Nucleic acids research.

[23]  P. Enzinger,et al.  Esophageal cancer. , 2003, The New England journal of medicine.

[24]  Aliasgar Moiyadi,et al.  Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. , 2010, Journal of cancer research and therapeutics.

[25]  Zhu-Hong You,et al.  A novel approach based on KATZ measure to predict associations of human microbiota with non‐infectious diseases , 2016, Bioinform..

[26]  S. Manfredi Le cancer du côlon : du dépistage de masse au traitement personnalisé , 2014, Oncologie.

[27]  Dong Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[28]  Yun Xiao,et al.  Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer , 2011, Molecular Cancer Therapeutics.

[29]  Siu-Ming Yiu,et al.  Predicting drug-target interaction for new drugs using enhanced similarity measures and super-target clustering1 , 2014, 2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[30]  Yun Xiao,et al.  Prioritizing candidate disease miRNAs by integrating phenotype associations of multiple diseases with matched miRNA and mRNA expression profiles. , 2014, Molecular bioSystems.

[31]  Alberto Izzotti,et al.  MicroRNAs: Modulators of Cell Identity, and their Applications in Tissue Engineering , 2014, MicroRNA.

[32]  F. Sarkar,et al.  MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. , 2012, Carcinogenesis.

[33]  Jian-Yu Shi,et al.  Predicting drug-target interaction for new drugs using enhanced similarity measures and super-target clustering. , 2015, Methods.

[34]  Xing Chen,et al.  RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.

[35]  J. Sun,et al.  miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer , 2012, British Journal of Cancer.

[36]  Zhu-Hong You,et al.  Detection of Interactions between Proteins through Rotation Forest and Local Phase Quantization Descriptors , 2015, International journal of molecular sciences.

[37]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[38]  Jan Gorodkin,et al.  Protein-driven inference of miRNA–disease associations , 2013, Bioinform..

[39]  Yukio Kitade,et al.  Downregulation of microRNAs‐143 and ‐145 in B‐cell malignancies , 2007, Cancer science.

[40]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[41]  Yufei Huang,et al.  Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors , 2013, PloS one.

[42]  G. Ruvkun,et al.  Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans , 1993, Cell.

[43]  Wanqing Chen,et al.  Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries , 2015, Thoracic cancer.

[44]  Sandro Banfi,et al.  microRNAs and genetic diseases , 2009, PathoGenetics.

[45]  M K Schwartz,et al.  Enzymes in colon cancer. General information , 1975 .